Net proceeds to support general corporate purposes, including future expansion opportunities fueled by strategic AI and member experience initiatives as well as the potential extension of enhanced ...
10x Genomics is bolstering its commitment to scaling single cell experiments through the acquisition of Scale Biosciences. 10x has agreed to pay $30 million in cash and stock upfront, plus an ...
CoreWeave plans a $2 billion convertible note offering as it scales AI infrastructure, following a yearlong pursuit of Core Scientific for added power capacity. AI infrastructure provider CoreWeave ...
On December 15, BTIG analyst Nick Altmann initiated coverage of Klaviyo, Inc. (NYSE:KVYO) stock with a Buy rating and $40 price target. Since its IPO, the company has remained one of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results